Cargando…
CtBP determines ovarian cancer cell fate through repression of death receptors
C-terminal binding protein 2 (CtBP2) is elevated in epithelial ovarian cancer, especially in the aggressive and highly lethal subtype, high-grade serous ovarian cancer (HGSOC). However, whether HGSOC tumor progression is dependent on CtBP2 or its paralog CtBP1, is not well understood. Here we report...
Autores principales: | Ding, Boxiao, Yuan, Fang, Damle, Priyadarshan K., Litovchick, Larisa, Drapkin, Ronny, Grossman, Steven R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181866/ https://www.ncbi.nlm.nih.gov/pubmed/32332713 http://dx.doi.org/10.1038/s41419-020-2455-7 |
Ejemplares similares
-
An intestinal stem cell niche in Apc mutated neoplasia targetable by CtBP inhibition
por: Chawla, Ayesha T., et al.
Publicado: (2018) -
CtBP2 proteome: Role of CtBP in E2F7-mediated repression and cell proliferation
por: Zhao, Ling-Jun, et al.
Publicado: (2014) -
Bcl-xL is translocated to the nucleus via CtBP2 to epigenetically promote metastasis
por: Zhang, Tiantian, et al.
Publicado: (2023) -
Role of the unique N-terminal domain of CtBP2 in determining the subcellular localisation of CtBP family proteins
por: Bergman, Lee M, et al.
Publicado: (2006) -
DNA methylation is involved in the pathogenesis of osteoarthritis by regulating CtBP expression and CtBP-mediated signaling
por: Sun, Xiangxiang, et al.
Publicado: (2020)